Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is a Third Dose of Measles-mumps-rubella-(Varicella) Vaccine (MMR(V)) Vaccine Beneficial for the Adult Population in Alberta?

NCT05923970 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT05923970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05923970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is a Third Dose of Measles-mumps-rubella-(Varicella) Vaccine (MMR(V)) Vaccine Beneficial for the Adult Population in Alberta?
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Recruiting
Start date
November 9, 2024
Completion date
September 30, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaccination failure, vaccine response impaired